09
Apr 2015Mylan Proposes Bid to Buy Perrigo for $28.9B
The combination of Mylan and Perrigo could form one of the world’s largest generic drug makers.
07
Apr 2015Astellas, MD Anderson: Agreement to Research, Develop AML Treatment
Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center today announced the signing of an option agreement to research and develop a new treatment for patients with acute myeloid leukemia (AML).
07
Apr 2015European Biotech’s American Dream
If you can’t beat them, join them. European biotech companies increasingly look across the Atlantic where investors’ enthusiasm for nascent health-care companies seemingly knows no bounds.
07
Apr 2015GlaxoSmithKline to open global R&D center in Rockville
The GlaxoSmithKline company logo is seen on the GlaxoSmithKline Plc headquarters in London, U.K. The pharmaceutical giant announced Thursday it will located its U.S. vaccine research and development in Rockville. Pharmaceutical giant GlaxoSmithKline PLC will open a new global center for vaccine research and development in Rockville, the company announced Thursday .
07
Apr 2015Bristol-Myers, uniQure enter cardiovascular gene therapy deal – Pharmaceutical Business Review
Bristol-Myers Squibb (BMS) and Netherlands-based uniQure have entered into exclusive strategic collaboration to develop gene therapies for cardiovascu
07
Apr 2015Schrödinger, Sanofi sign $120m drug discovery deal – Pharmaceutical Business Review
US-based computational drug designer Schrödinger has entered into a multi-year early drug discovery collaboration with Sanofi in which Schrödinger wil
03
Apr 2015Innovation Prize 2015: Make the right moves in your project development
The Innovation Prize is an opportunity catalyst ! Since the begining of this event, 8 finalists start-ups signed a licence with a pharmaceutical company . Altogether, and thanks to the visibility offe red by the Prize, more than 50% of those start-ups raised fund for their project! Participate in the 6th edition of the Innovation Days ! Innovation Prize 2015 Team Innovation…
01
Apr 2015Financement de 21 millions US pour une biotech montréalaise | Martin Vallières | Santé
Thrasos Therapeutics, société de biotechnologie de Montréal qui développe des traitements préventifs contre l’insuffisance rénale, a conclu un nouveau financement de…
01
Apr 2015La biotech vise un marché de plus de 300 millions d’euros
Nous venons de rencontrer le directeur financier d AB Science, Laurent Guy, dans le cadre des Rencontres PEA PME organisées par Portzamparc au Palais Brongniart. AB Science, qui emploie 120…
01
Apr 2015Neovacs : Néovacs et Stellar Biotechnologies étendent leur collaboration | Zone bourse
Néovacs et Stellar Biotechnologies étendent leur collaboration Accord qui garantit l’approvisionnement en KLH pour les prochaines études cliniques de… | 1 avril 2015